Merrimack Pharmaceuticals (MACK) Revenue (2012 - 2024)
Merrimack Pharmaceuticals (MACK) revenue from Mar 31, 2012 to Mar 31, 2024. The TTM Merrimack Pharmaceuticals (MACK) revenue is $0. You can adjust inflation or export chart.
Annual Revenue
Quarterly Revenue
Annual Revenue change of Merrimack Pharmaceuticals (MACK)
| Year | Revenue | Change |
|---|---|---|
| 2024 | $0 | N/A |
| 2023 | $0 | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | N/A |
| 2018 | $0 | N/A |
| 2017 | $0 | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | -100.00% |
| 2014 | $103M | +115.02% |
| 2013 | $48M | -2.31% |
| 2012 | $49M | N/A |